跳至主要内容
临床试验/NCT02078479
NCT02078479已完成不适用

Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain Secondary to Malignancy.

Assiut University0 个研究点目标入组 34 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
主要终点
Neuropathic pain improvement

研究概览

简要总结

The purpose of this study isto assess the efficacy of daily 10 sessions of rTMS over primary motor cortex in patients suffering from malignant neuropathic pain. Thirty four patients were divided randomly into 2 groups equally using closed envelops to undergo real (20 Hz, 10 second, 10 trains with inter-train interval 30 second with total pulses 2000, intensity 80% of motor threshold over hand area of motor cortex) or sham rTMS (same parameters but with coil elevated and angled away from the head)every day for ten consecutive days (5 days/week). Patients were evaluated using a verbal descriptor scale (VDS), visual analog scale (VAS), Leeds assessment of neuropathic symptoms and signs (LANSS) and Hamilton rating scale for depression (HAM-D) at baseline, after 1st, 5th, 10thtreatment session, and then 15 days and 1 month after the end of treatment. ic pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients within age group 18-65 years with malignant lateralized neuropathic pain resistant to medical treatment for at least 2 months or associated with significant adverse effects from medication were involved in this study.

排除标准

  • Patients with intracranial metallic devices Patients with pacemakers or any other device. Patients with recent myocardial ischemia, unstable angina Patients known to have history of epilepsy.

结局指标

主要结局

Neuropathic pain improvement

时间窗: one month

Reduction of neuropathic pain in patients with malignancy measured by VDS, VAS, LANSS.

次要结局

  • Reduction of depression manifestation(one month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eman M. Khedr

Clinical Professor

Assiut University

相似试验